Moderna
MRNA
$137.90
Share price
-1.52%
Change (1 day)
7.12%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Net assets
Net assets on the balance sheet as of March 2024 : $12.81 B
According to Moderna
's latest financial reports the company has $12.81 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Moderna - Net assets on balance sheet (from 2017 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $13.85 B | -27.55% |
| 2022-12-31 | $19.12 B | 35.19% |
| 2021-12-31 | $14.14 B | 452.32% |
| 2020-12-31 | $2.56 B | 117.99% |
| 2019-12-31 | $1.17 B | -23.23% |
| 2018-12-31 | $1.53 B | 144.72% |
| 2017-12-31 | $0.62 B | -25.72% |
| 2016-12-31 | $0.84 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 446.31% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 210.18% | 🇨🇭 Switzerland |
 Merck MRK | $40.42 B | 215.39% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $0.10 B | -99.16% | 🇺🇸 USA |
 Athersys ATHX | -$36.4 M | -100.28% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.22 B | -101.71% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.49 B | -96.13% | 🇺🇸 USA |